In February 2018, the FDA issued early guidance on clinical trials for early Alzheimer’s disease. The document lays out the FDA’s thinking on how to meaningfully include patients in clinical trials at the earliest stages of the disease. The attached document is a sign-on comment letter circulated by ACT-AD in response to the draft guidance.
Valve Disease Day
is Almost Here!
February is American Heart Month, a time to raise awareness around the importance of recognizing and understanding all types of heart disease, including valve disease.
Learn more about #ValveDiseaseDay events happening throughout Heart Month and on February 22nd, that encourage us all to listen to our hearts.